Data / Drug companies / Vantive US Healthcare LLC
Vantive US Healthcare LLC: 33 products in the FDA NDC directory, labeler code 0941
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Vantive US Healthcare LLC (labeler code 0941) lists 33 products in the FDA National Drug Code Directory. By type: 33 prescription drugs. Its main marketing category is unapproved drugs for a shortage. The newest product started marketing on November 7, 2024.
The request: Watch Vantive US Healthcare LLC (FDA labeler code 0941): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0941
- Products in commercial distribution
- 33
- Packages
- 66
- Finished drugs by generic name
- 0
- Prescription products
- 33
- Over the counter products
- 0
- Flagged as original packager
- 33 of 33 products that carry the flag
- Started marketing in the last 12 months
- 0
- Products with a marketing end date set
- 17
- Earliest marketing start
- September 27, 1978
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Unapproved drugs for a shortage | 17 | 51.5% |
| New drug applications (NDA) | 16 | 48.5% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 33 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 33 | 100% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Blood Coagulation Factor | 33 |
| Calculi Dissolution Agent | 33 |
| Osmotic Laxative | 33 |
| Phosphate Binder | 33 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Dianeal low calcium with dextrose | 0941-0703 | Injection, solution | Unapproved drugs for a shortage | November 7, 2024 |
| Dianeal low calcium with dextrose | 0941-0701 | Injection, solution | Unapproved drugs for a shortage | November 7, 2024 |
| Dianeal low calcium with dextrose | 0941-0735 | Injection, solution | Unapproved drugs for a shortage | November 6, 2024 |
| Dianeal low calcium with dextrose | 0941-0733 | Injection, solution | Unapproved drugs for a shortage | November 6, 2024 |
| Dianeal low calcium with dextrose | 0941-0692 | Injection, solution | Unapproved drugs for a shortage | November 1, 2024 |
| Dianeal low calcium with dextrose | 0941-0688 | Injection, solution | Unapproved drugs for a shortage | November 1, 2024 |
| Dianeal low calcium with dextrose | 0941-0686 | Injection, solution | Unapproved drugs for a shortage | November 1, 2024 |
| Dianeal low calcium with dextrose | 0941-0684 | Injection, solution | Unapproved drugs for a shortage | November 1, 2024 |
| Dianeal pd-2 with dextrose | 0941-0698 | Injection, solution | Unapproved drugs for a shortage | October 30, 2024 |
| Dianeal low calcium with dextrose | 0941-0696 | Injection, solution | Unapproved drugs for a shortage | October 30, 2024 |
| Dianeal low calcium with dextrose | 0941-0731 | Injection, solution | Unapproved drugs for a shortage | October 29, 2024 |
| Dianeal low calcium with dextrose | 0941-0729 | Injection, solution | Unapproved drugs for a shortage | October 29, 2024 |
| Dianeal low calcium with dextrose | 0941-0727 | Injection, solution | Unapproved drugs for a shortage | October 29, 2024 |
| Dianeal low calcium with dextrose | 0941-0705 | Injection, solution | Unapproved drugs for a shortage | October 28, 2024 |
| Extraneal | 0941-0707 | Injection, solution | Unapproved drugs for a shortage | October 23, 2024 |
| Extraneal | 0941-0681 | Injection, solution | Unapproved drugs for a shortage | October 21, 2024 |
| Extraneal | 0941-0681 | Injection, solution | Unapproved drugs for a shortage | October 21, 2024 |
| Extraneal | 0941-0679 | Injection, solution | New drug applications (NDA) | December 20, 2002 |
| DIANEAL Low Calcium with Dextrose | 0941-0433 | Injection, solution | New drug applications (NDA) | December 4, 1992 |
| DIANEAL Low Calcium with Dextrose | 0941-0430 | Injection, solution | New drug applications (NDA) | December 4, 1992 |
| DIANEAL PD-2 with Dextrose | 0941-0429 | Injection, solution | New drug applications (NDA) | December 4, 1992 |
| DIANEAL PD-2 with Dextrose | 0941-0427 | Injection, solution | New drug applications (NDA) | December 4, 1992 |
| DIANEAL PD-2 with Dextrose | 0941-0426 | Injection, solution | New drug applications (NDA) | December 4, 1992 |
| DIANEAL Low Calcium with Dextrose | 0941-0424 | Injection, solution | New drug applications (NDA) | December 4, 1992 |
| DIANEAL Low Calcium with Dextrose | 0941-0490 | Injection, solution | New drug applications (NDA) | September 27, 1978 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.